03:55 PM EST - Medicago Inc. : announced an extension to its partnering agreement of July 2009 with Genopole®. Medicago and Genopole® will also work towards the creation a laboratory for research on vaccine and antibody targets of interest for France in terms of public health and biodefense. This laboratory is planned to involve French academic research institutes and will be located at the Genopole® biopark in Evry, France. Medicago Inc.
shares T.MDG are trading down $0.015 at $0.40.
